During the past decade, Ospedale Arnaboldi conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ospedale Arnaboldi" are "Hypertension" (2 trials). Many other conditions were trialed in "Ospedale Arnaboldi" in a lesser frequency.

Most popular intervention types in "Ospedale Arnaboldi" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fixed dose combination telmisartan 80 mg + HCTZ 12.5 mg" (1 trials), "Fixed dose combination telmisartan 80 mg + HCTZ 25 mg" (1 trials) and "telmisartan 80 mg + hydrochlorothiazide 25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Arnaboldi" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Arnaboldi". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ospedale Arnaboldi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Arnaboldi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Ospedale Arnaboldi has several departments that took part in Clinical trials: "Ospedale Civile, Cardiologia" - 3 trials